Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort. 2019

Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
Departamento de Reumatologia, Universidade de Brasília, Brasília, Distrito Federal, Brazil.

The treatment of rheumatoid arthritis (RA) has evolved rapidly in recent years. Nonetheless, conventional synthetic disease-modifying drugs (csDMARDs) remain the gold standard for RA treatment. The treatment for RA is expensive and this has a negative impact on public health. Given the low cost of csDMARDs compared to those of other treatment strategies, it is important to manage this type of treatment properly. Information on the duration of use of each drug and the reasons for their discontinuation is relevant to medical practitioners as it could improve the information available regarding side effects and their proper management. Moreover, data from clinical practice in the population can provide health care managers with information for resource allocation and optimization of csDMARD use with a consequent cost reduction in the treatment of RA. In this cross-sectional study, we aimed to describe the use of csDMARDs in public health services in Brazil, emphasizing on the duration of use and reasons for discontinuation of each drug. This study is a part of the REAL, a multicenter project that evaluated Brazilian patients with RA from eleven rheumatology services from August to October 2015. Patients were examined clinically, and an analysis of complementary exams and medical records was performed. A total of 1125 patients were included. 98.5% were women with a median age of 55.6 years. 36% and 90.84% patients were using biological disease-modifying drugs (bDMARDs) and csDMARDs, respectively. The duration of use and doses of each medication and the causes of suspension were analyzed. Most of the patients analyzed in this study were using csDMARDs for prolonged periods and methotrexate showed the longest duration of use. Interruption indexes due to ineffectiveness and side effects were analyzed. The knowledge of common adverse effects may alert attending physicians to the proper management of effective and low-cost therapeutic groups.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076742 Synthetic Drugs Legal or illegal drugs created using SYNTHETIC CHEMISTRY TECHNIQUES. Synthesized Drugs,Synthetic Drug,Drug, Synthetic,Drugs, Synthesized,Drugs, Synthetic
D000077339 Leflunomide An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. Arava,HWA 486,HWA-486,N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide,SU101,HWA486
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
December 2018, Arthritis care & research,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
May 2022, Joint bone spine,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
March 2023, JAMA,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
September 1995, Annals of the rheumatic diseases,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
January 2022, PloS one,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
February 2017, The Journal of rheumatology,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
January 2021, Clinical and experimental rheumatology,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
January 1986, Clinical therapeutics,
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
March 2020, Advances in rheumatology (London, England),
Ana Paula Monteiro Gomides, and Cleandro Pires de Albuquerque, and Ana Beatriz Vargas Santos, and Rodrigo Balbino Chaves Amorim, and Manoel Barros Bértolo, and Paulo Louzada Júnior, and Isabela Araújo Santos, and Rina Dalva Neubarth Giorgi, and Nathalia de Carvalho Sacilotto, and Sebastião Cezar Radominski, and Fernanda Maria Borghi, and Maria Fernanda B Resende Guimarães, and Maria Raquel da Costa Pinto, and Gustavo Gomes Resende, and Karina Rossi Bonfiglioli, and Henrique Carriço da Silva, and Maria de Fátima Lobato da Cunha Sauma, and Marcel Lobato Sauma, and Júlia Brito de Medeiros, and Ivânio Alves Pereira, and Gláucio Ricardo Wernwer de Castro, and Claiton Viegas Brenol, and Ricardo Machado Xavier, and Licia Maria Henrique da Mota, and Geraldo da Rocha Castelar Pinheiro
July 2021, Modern rheumatology,
Copied contents to your clipboard!